Trials / Completed
CompletedNCT02948946
Clinical Utility Assay as a Biomarker for Gastroenteropancreatic and Lung Neuroendocrine Tumors
The Clinical Utility of a Blood-Based Multitranscriptome Assay as a Biomarker for Gastroenteropancreatic and Lung Neuroendocrine Tumors
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 105 (actual)
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate how well an investigational blood test performs. The study will look at the sensitivity and specificity of a blood-based multitranscriptome assay (NETest).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | NETest | 5 mL of blood will be drawn from participants for testing. |
Timeline
- Start date
- 2017-01-09
- Primary completion
- 2018-08-24
- Completion
- 2020-09-15
- First posted
- 2016-10-31
- Last updated
- 2021-08-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02948946. Inclusion in this directory is not an endorsement.